1. Coltman CA, Dahlberg S, Jones SE, et al.: CHOP is curative in thirty percent of patients with large cell lymphoma: a twelve year Southwest Oncology Group follow-up. In AT Skarin, ed. Advances in Cancer Chemotherapy. New York: Park Row, 1986, pp 71–77.
2. Klimo P, Connors JM: MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 102:596–602, 1985.
3. Coleman, M: Chemotherapy for large-cell lymphoma: Optimism and caution. Ann Intern Med 103:140–142, 1985.
4. Skarin A, Canellos G, Rosenthal D, et al.: Moderate dose methotrexate combined with bleomycin, adriamycin, cyclophosphamide, Oncovin, and dexamethasome, m-BACOD, in advanced diffuse histiocytic lymphoma. Proc Am Soc Clin Oncol 2:220, 1983.
5. Fisher RI, DeVita VT, Hubbard SM, et al.: Randomized trial of ProMACE-MOPP vs. ProMACE-CytaBOM in previously untreated, advanced diffuse aggressive lymphomas. Proc Am Soc Clin Oncol 3:242, 1984.